|
Copyright © Doctor Health Solution - All Rights Reserved
Marketing Company's office Address: INTER P LTD ,24 Start Light, Oyo state.
Marketing Company's office Address: INTER P LTD ,24 Start Light, Oyo state.
Monday 14 November 2016
how to enlarge my penis
Saturday 5 March 2016
emdee shipping and maritime college
Scores of eager candidates of the Joint Admission and Matriculation Board (JAMB) have been besieging the campuses of some maritime institutions in Lagos to inquire about their admission status.
The rush which became noticeable early last week was ahead of the October 31 deadline given by JAMB to the maritime colleges to tidy up their admission.
Shipping Position Daily received telephone calls from several anxious JAMB candidates seeking clarifications about these schools.
However most of the enquiries were about the location of Emdee Shipping and Maritime College in Apapa, Lagos.
Majority of those who called last week acknowledged their ignorance about the maritime industry and shipping in particular, but expressed willingness to take advantage of their being offered admission by JAMB to study shipping.
From our telephone interactions with them, it was also discovered that many of them are also based in Lag and adjoining states.
Confirming the development, the Registrar of Emdee Shipping and Maritime College; Mrs Otuyemi Laide told our correspondent also last week that the college is fully prepared for the new intakes.
“We have been expecting them; we have the facilities that will make their learning rewarding one. As a matter of fact, many of them have already been here, you know that admission will close by end of October”, she disclosed.
Asked specifically about the facilities that are on ground, the Registrar confirmed that the college now has a full-facilities hostel and a well –equipped library as well as modern lecture halls.
“We are serious about it when we said that Emdee Shipping and Maritime College will receive the first batch of JAMB candidates into the Nigerian maritime industry”.
Monday 1 February 2016
Nigeria Army in war Against Rat
Nigeria Army in war Against Rat
After the Ebola crisis of 2014, Nigeria is now facing the spread of Lassa Fever.
Lassa Alert, a collective led by Federal Ministry of Health. The Nigeria Center for Disease Control and Partners are focusing to spreading awareness to help stop the spread of the disease. Lassa Alert has shared key information about the disease which has now been confirmed in several states around Nigeria.
Lassa Alert, a collective led by Federal Ministry of Health. The Nigeria Center for Disease Control and Partners are focusing to spreading awareness to help stop the spread of the disease. Lassa Alert has shared key information about the disease which has now been confirmed in several states around Nigeria.
Over 40 people in 10 states have been confirmed dead since this outbreak started.
Key facts
Lassa fever is an acute viral haemorrhagic illness of 1-4 weeks duration that occurs in West Africa.
The Lassa virus is transmitted to humans via contact with food or household items contaminated with rodent urine or faeces.
Person-to-person infections and laboratory transmission can also occur, particularly in hospitals lacking adequate infection prevent and control measures.
Lassa fever is known to be endemic in Benin (where it was diagnosed for the first time in November 2014), Guinea, Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.
Lassa fever is an acute viral haemorrhagic illness of 1-4 weeks duration that occurs in West Africa.
The Lassa virus is transmitted to humans via contact with food or household items contaminated with rodent urine or faeces.
Person-to-person infections and laboratory transmission can also occur, particularly in hospitals lacking adequate infection prevent and control measures.
Lassa fever is known to be endemic in Benin (where it was diagnosed for the first time in November 2014), Guinea, Liberia, Sierra Leone and parts of Nigeria, but probably exists in other West African countries as well.
The overall case-fatality rate is 1%. Observed case-fatality rate among patients hospitalized with severe cases of Lassa fever is 15%.
Early supportive care with rehydration and symptomatic treatment improves survival.
Background
Though first described in the 1950s, the virus causing Lassa disease was not identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae.
Though first described in the 1950s, the virus causing Lassa disease was not identified until 1969. The virus is a single-stranded RNA virus belonging to the virus family Arenaviridae.
About
80% of people who become infected with Lassa virus have no symptoms.
One in five infections result in severe disease, where the virus affects
several organs such as the liver, spleen and kidneys.
Lassa
fever is a zoonotic disease, meaning that humans become infected from
contact with infected animals. The animal reservoir, or host, of Lassa
virus is a rodent of the genus Mastomys, commonly known as the
“multimammate rat.” Mastomys rats infected with Lassa virus do not
become ill, but they can shed the virus in their urine and faeces.
Because
the clinical course of the disease is so variable, detection of the
disease in affected patients has been difficult. However, when presence
of the disease is confirmed in a community, prompt isolation of affected
patients, good infection protection and control practices and rigorous
contact tracing can stop outbreaks.
Symptoms of Lassa fever
The
incubation period of Lassa fever ranges from 6-21 days. The onset of
the disease, when it is symptomatic, is usually gradual, starting with
fever, general weakness, and malaise. After a few days, headache, sore
throat, muscle pain, chest pain, nausea, vomiting, diarrhoea, cough, and
abdominal pain may follow. In severe cases facial swelling, fluid in
the lung cavity, bleeding from the mouth, nose, vagina or
gastrointestinal tract and low blood pressure may develop. Protein may
be noted in the urine. Shock, seizures, tremor, disorientation, and coma
may be seen in the later stages. Deafness occurs in 25% of patients who
survive the disease. In half of these cases, hearing returns partially
after 1-3 months. Transient hair loss and gait disturbance may occur
during recovery. Death usually occurs within 14 days of onset in fatal
cases. The disease is especially severe late in pregnancy, with maternal
death and/or fetal loss occurring in greater than 80% of cases during
the third trimester.
Symptoms of Lassa fever
The
incubation period of Lassa fever ranges from 6-21 days. The onset of
the disease, when it is symptomatic, is usually gradual, starting with
fever, general weakness, and malaise. After a few days, headache, sore
throat, muscle pain, chest pain, nausea, vomiting, diarrhoea, cough, and
abdominal pain may follow. In severe cases facial swelling, fluid in
the lung cavity, bleeding from the mouth, nose, vagina or
gastrointestinal tract and low blood pressure may develop. Protein may
be noted in the urine. Shock, seizures, tremor, disorientation, and coma
may be seen in the later stages. Deafness occurs in 25% of patients who
survive the disease. In half of these cases, hearing returns partially
after 1-3 months. Transient hair loss and gait disturbance may occur
during recovery. Death usually occurs within 14 days of onset in fatal
cases. The disease is especially severe late in pregnancy, with maternal
death and/or fetal loss occurring in greater than 80% of cases during
the third trimester.
Transmission
Humans usually become infected with Lassa virus from exposure to urine or faeces of infected Mastomys rats. Lassa virus may also be spread between humans through direct contact with the blood, urine, faeces, or other bodily secretions of a person infected with Lassa fever. There is no epidemiological evidence supporting airborne spread between humans. Person-to-person transmission occurs in both community and health-care settings, where the virus may be spread by contaminated medical equipment, such as re-used needles. Sexual transmission of Lassa virus has been reported.
Humans usually become infected with Lassa virus from exposure to urine or faeces of infected Mastomys rats. Lassa virus may also be spread between humans through direct contact with the blood, urine, faeces, or other bodily secretions of a person infected with Lassa fever. There is no epidemiological evidence supporting airborne spread between humans. Person-to-person transmission occurs in both community and health-care settings, where the virus may be spread by contaminated medical equipment, such as re-used needles. Sexual transmission of Lassa virus has been reported.
Lassa fever occurs
in all age groups and both sexes. Persons at greatest risk are those
living in rural areas where Mastomys are usually found, especially in
communities with poor sanitation or crowded living conditions. Health
workers are at risk if caring for Lassa fever patients in the absence of
proper barrier nursing and infection control practices.
Diagnosis
Because the symptoms of Lassa fever are so varied and non-specific, clinical diagnosis is often difficult, especially early in the course of the disease. Lassa fever is difficult to distinguish from other viral haemorrhagic fevers such as Ebola virus disease; and many other diseases that cause fever, including malaria, shigellosis, typhoid fever and yellow fever.
Because the symptoms of Lassa fever are so varied and non-specific, clinical diagnosis is often difficult, especially early in the course of the disease. Lassa fever is difficult to distinguish from other viral haemorrhagic fevers such as Ebola virus disease; and many other diseases that cause fever, including malaria, shigellosis, typhoid fever and yellow fever.
Definitive diagnosis
requires testing that is available only in specialized laboratories.
Laboratory specimens may be hazardous and must be handled with extreme
care. Lassa virus infections can only be diagnosed definitively in the
laboratory using the following tests:
antibody enzyme-linked immunosorbent assay (ELISA)
antigen detection tests
reverse transcriptase polymerase chain reaction (RT-PCR) assay
virus isolation by cell culture.
antigen detection tests
reverse transcriptase polymerase chain reaction (RT-PCR) assay
virus isolation by cell culture.
Treatment and vaccines
The antiviral drug ribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness. There is no evidence to support the role of ribavirin as post-exposure prophylactic treatment for Lassa fever.
The antiviral drug ribavirin seems to be an effective treatment for Lassa fever if given early on in the course of clinical illness. There is no evidence to support the role of ribavirin as post-exposure prophylactic treatment for Lassa fever.
There is currently no vaccine that protects against Lassa fever.
Prevention and control
Prevention
of Lassa fever relies on promoting good “community hygiene” to
discourage rodents from entering homes. Effective measures include
storing grain and other foodstuffs in rodent-proof containers, disposing
of garbage far from the home, maintaining clean households and keeping
cats. Because Mastomys are so abundant in endemic areas, it is not
possible to completely eliminate them from the environment. Family
members should always be careful to avoid contact with blood and body
fluids while caring for sick persons.
Prevention
of Lassa fever relies on promoting good “community hygiene” to
discourage rodents from entering homes. Effective measures include
storing grain and other foodstuffs in rodent-proof containers, disposing
of garbage far from the home, maintaining clean households and keeping
cats. Because Mastomys are so abundant in endemic areas, it is not
possible to completely eliminate them from the environment. Family
members should always be careful to avoid contact with blood and body
fluids while caring for sick persons.
In
health-care settings, staff should always apply standard infection
prevention and control precautions when caring for patients, regardless
of their presumed diagnosis. These include basic hand hygiene,
respiratory hygiene, use of personal protective equipment (to block
splashes or other contact with infected materials), safe injection
practices and safe burial practices.
Health
workers caring for patients with suspected or confirmed Lassa fever
should apply extra infection control measures to prevent contact with
the patient’s blood and body fluids and contaminated surfaces or
materials such as clothing and bedding. When in close contact (within 1
metre) of patients with Lassa fever, health-care workers should wear
face protection (a face shield or a medical mask and goggles), a clean,
non-sterile long-sleeved gown, and gloves (sterile gloves for some
procedures).
Laboratory workers are
also at risk. Samples taken from humans and animals for investigation of
Lassa virus infection should be handled by trained staff and processed
in suitably equipped laboratories.
On
rare occasions, travellers from areas where Lassa fever is endemic
export the disease to other countries. Although malaria, typhoid fever,
and many other tropical infections are much more common, the diagnosis
of Lassa fever should be considered in febrile patients returning from
West Africa, especially if they have had exposures in rural areas or
hospitals in countries where Lassa fever is known to be endemic.
Health-care workers seeing a patient suspected to have Lassa fever
should immediately contact local and national experts for advice and to
arrange for laboratory testing.
WHO response
The Ministries of Health of Guinea, Liberia and Sierra Leone, WHO, the Office of United States Foreign Disaster Assistance, the United Nations, and other partners have worked together to establish the Mano River Union Lassa Fever Network. The programme supports these 3 countries in developing national prevention strategies and enhancing laboratory diagnostics for Lassa fever and other dangerous diseases. Training in laboratory diagnosis, clinical management, and environmental control is also included. In addition, a new ward dedicated to the care of patients with Lassa fever is under construction in Sierra Leone, sponsored by the European Union
The Ministries of Health of Guinea, Liberia and Sierra Leone, WHO, the Office of United States Foreign Disaster Assistance, the United Nations, and other partners have worked together to establish the Mano River Union Lassa Fever Network. The programme supports these 3 countries in developing national prevention strategies and enhancing laboratory diagnostics for Lassa fever and other dangerous diseases. Training in laboratory diagnosis, clinical management, and environmental control is also included. In addition, a new ward dedicated to the care of patients with Lassa fever is under construction in Sierra Leone, sponsored by the European Union
Rat Threatens Nigeria
Rat threatens Nigeria
No
fewer than two persons have been confirmed dead at the Dalhatu
Specialist Hospital in Lafia, the Nasarawa State capital, following the
outbreak of Lassa fever in the state.
The state commissioner for health, Dr
Daniel Iya, confirmed the incident in Lafia during a public hearing
organised by the Nasarawa State House of Assembly’s committee on health.
Iya disclosed that one victim was still under surveillance while another has been discharged.
He said the state did not have an
isolation unit but only isolation rooms at the DASH, adding that there
was no single isolation unit for the treatment of Lassa fever across the
state.
The commissioner also hinted that
Governor Umaru Al-Makura had already released the sum of N5.9m to
control the spread of the virus across the state, promising to build an
isolation unit in the state capital to effectively isolate and treat
persons affected with the virus.
He said, “We have already bought 2000
injections of Ribavirin, 1000 tablets of Rivabirin and we are tracking
about 130 persons in the state.”
According to him, there are plans are by
the state ministry of health to sensitise people at the grass-roots on
Lassa fever from next month.
Meanwhile, a Professor of Virology and
President, Nigerian Academy of Science, Prof. Oyewale Tomori, has said
the country may be at risk of the mosquito-borne Zika virus infection
and needs to prevent it from spreading into the country from Latin
America.
Tomori, who spoke to our correspondent
on the telephone on Saturday, said a mild strain of the Zika virus had
been discovered in Nigeria decades ago, but it was not a deadly one as
the one currently seen in Brazil and Latin America.
Tomori, who also chairs the Federal
Government’s Multi-sectorial Committee on the eradication of Lassa
fever, advised Nigerians to maintain good personal and environmental
hygiene.
He said, “We have to prepare for
anything that comes, for any eventuality. We never thought that Ebola
was going to come here, so we have to be prepared for everything at all
times. Presently, there is no vaccine for Zika virus.
“People should protect themselves from
mosquitoes by keeping their environment clean and maintaining good
personal hygiene, like in the case of Lassa fever, keep your environment
clean so that rodents won’t come into your house. It is the same with
mosquitoes.
“Don’t keep stagnant pools of water in
the neighbourhood; keep your environment clean so as not to encourage
the breeding of mosquitoes that can possibly transmit these diseases.
“There is no doubt that the mosquito
that can transmit Zika is in Nigeria. We have had evidence of it before.
Whether this would cause a major infection now, we don’t know. But
definitely we must prepare. Nigeria may be at risk, definitely. Already
the Ministry of Health had already issued an alert because they feared
that it may be a problem.”
Tomori added that his committee was
still in the preliminary stages of gathering data on Lassa fever
outbreak in the country. “Let me put it this way, I don’t want to
comment on it yet, there is still some validation going on. So, it would
be premature for me to make any comment for now,” he said.
Copyright PUNCH.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from PUNCH.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from PUNCH.
Friday 29 January 2016
emdee
emdee
Scores of eager candidates of the Joint Admission and Matriculations
Board (JAMB) have been besieging the campuses of some maritime
institutions in Lagos to enquire about their admission status.
The rush which became noticeable early last week was ahead of the October 31 deadline given by JAMB to the maritime colleges to tidy up their admission.
Shipping Position Daily received telephone calls from several anxious JAMB candidates seeking clarifications about these schools.
However most of the enquiries were about the location of Emdee Shipping and Maritime College in Apapa, Lagos.
Majority of those who called last week acknowledged their ignorance about the maritime industry and shipping in particular, but expressed willingness to take advantage of their being offered admission by JAMB to study shipping.
From our telephone interactions with them, it was also discovered that many of them are also based in Lag and adjoining states.
Confirming the development, the Registrar of Emdee Shipping and Maritime College; Mrs Otuyemi Laide told our correspondent also last week that the college is fully prepared for the new intakes.
“We have been expecting them; we have the facilities that will make their learning rewarding one. As a matter of fact, many of them have already been here, you know that admission will close by end of October”, she disclosed.
Asked specifically about the facilities that are on ground, the Registrar confirmed that the college now has a full-facilities hostel and a well –equipped library as well as modern lecture halls.
“We are serious about it when we said that Emdee Shipping and Maritime College will receive the first batch of JAMB candidates into the Nigerian maritime industry”.
The rush which became noticeable early last week was ahead of the October 31 deadline given by JAMB to the maritime colleges to tidy up their admission.
Shipping Position Daily received telephone calls from several anxious JAMB candidates seeking clarifications about these schools.
However most of the enquiries were about the location of Emdee Shipping and Maritime College in Apapa, Lagos.
Majority of those who called last week acknowledged their ignorance about the maritime industry and shipping in particular, but expressed willingness to take advantage of their being offered admission by JAMB to study shipping.
From our telephone interactions with them, it was also discovered that many of them are also based in Lag and adjoining states.
Confirming the development, the Registrar of Emdee Shipping and Maritime College; Mrs Otuyemi Laide told our correspondent also last week that the college is fully prepared for the new intakes.
“We have been expecting them; we have the facilities that will make their learning rewarding one. As a matter of fact, many of them have already been here, you know that admission will close by end of October”, she disclosed.
Asked specifically about the facilities that are on ground, the Registrar confirmed that the college now has a full-facilities hostel and a well –equipped library as well as modern lecture halls.
“We are serious about it when we said that Emdee Shipping and Maritime College will receive the first batch of JAMB candidates into the Nigerian maritime industry”.
Subscribe to:
Posts (Atom)